Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1369
| Despition | Parkin Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1085 | Recombinant Human alpha Internexin Protein (AC1085) | 25 µl | inquiry |
| ACPP-1424 | Human IMPA2 Protein (AC1424) | 2 µg | inquiry |
| ACPP-1767 | Human YIF1B Protein (AC1767) | 5 µg | inquiry |
| ACPP-1121 | Recombinant Human GFAP Protein (AC1121) | 25 µl | inquiry |
| ACPP-1484 | Human CPE Protein (AC1484) | 5 µg | inquiry |
| ACPP-1740 | Human RCAN1 Protein (AC1740) | 5 µg | inquiry |
| ACPP-1531 | Human CHMP2B Protein (AC1531) | 5 µg | inquiry |
| ACPP-1080 | GABA B Receptor 2 Blocking Peptide (AC1080) | 250 µg | inquiry |
| ACPP-1738 | Human PNOC Protein (AC1738) | 5 µg | inquiry |
| ACPP-1486 | Rat VEGF C Protein (AC1486) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.